Table 2.
Prevalence of mf and the geometric mean intensity in the study area
| Age group (yrs) |
Individuals examined |
mf positive individual (%) |
*mf geometric mean intensity |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Female | Male | Total | Female | Male | Total | Female | Male | Total | mf positives only | |
| 1-14 |
242 |
252 |
494 |
2 (0.36) |
3 (0.56) |
5 (0.46) |
1.05 |
1.05 |
1.05 |
127.85 |
| 15-24 |
114 |
137 |
251 |
0 |
5 (0.93) |
5 (0.46) |
0 |
1.18 |
1.05 |
86.40 |
| 25-34 |
57 |
44 |
101 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 35-44 |
42 |
30 |
72 |
1 (0.18) |
0 |
1 (0.09) |
1.10 |
0 |
1.06 |
51 |
| 45+ |
92 |
73 |
165 |
3 (0.55) |
3 (0.56) |
6 (0.55) |
1.10 |
1.23 |
1.16 |
53.66 |
| All | 547 | 536 | 1083 | 6 (1.10) | 11 (2.05) | 17 (1.57) | 1.05 | 1.10 | 1.07 | 79.45 |
*Antilog [Σ log (x + 1)/ n], where x is the number of mf per ml of blood in mf individuals and n is the number of people examined [9].